Jeremy L. Jenkins, Ph.D.
Institution:
Ohio State University, Columbus, Columbus, OHArea:
Bacterial toxinsGoogle:
"Jeremy Jenkins"Mean distance: 21373.2
Parents
Sign in to add mentorDonald H. Dean | grad student | 2000 | Ohio State | |
(Investigation of the Bacillus thuringiensis insecticidal Cry1A toxin binding mechanism to lepidopteran midgut receptors.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Canham SM, Wang Y, Cornett A, et al. (2020) Systematic Chemogenetic Library Assembly. Cell Chemical Biology |
Ross NT, Lohmann F, Carbonneau S, et al. (2019) CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma. Nature Chemical Biology |
Moret N, Clark NA, Hafner M, et al. (2019) Cheminformatics Tools for Analyzing and Designing Optimized Small-Molecule Collections and Libraries. Cell Chemical Biology |
Nolin E, Gans S, Llamas L, et al. (2019) Discovery of a ZIP7 inhibitor from a Notch pathway screen. Nature Chemical Biology |
Ye C, Ho DJ, Neri M, et al. (2018) DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nature Communications. 9: 4307 |
Wang Y, Jenkins JL. (2018) Quantitative Prioritization of Tool Compounds for Phenotypic Screening. Methods in Molecular Biology (Clifton, N.J.). 1787: 195-206 |
Riba A, Emmenlauer M, Chen A, et al. (2017) Explicit Modeling of siRNA-Dependent On- and Off-Target Repression Improves the Interpretation of Screening Results. Cell Systems |
Paricharak S, IJzerman AP, Jenkins JL, et al. (2016) Data-driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening. Journal of Chemical Information and Modeling |
Wang Y, Cornett A, King FJ, et al. (2016) Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery. Cell Chemical Biology |
Schirle M, Jenkins JL. (2015) Identifying compound efficacy targets in phenotypic drug discovery. Drug Discovery Today |